Clinical Trial

BRINK (BRain In Kidney Disease) Memory Study 2.0

Study acronym: BRINK
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 4, 2025 (before its estimated May 2026 completion). Its status may not reflect the trial's current state.
Summary
In this study, the investigators will be looking at results of tests of memory and thinking and daily activities in a group of people without known chronic kidney disease (CKD) , and a group of CKD patients, and follow the participants for up to four more years, including after the participants start dialysis or receive a transplant. The investigators are doing this study to compare how often memory loss, confusion and difficulty with daily activities occur in those without and those with CKD. Additionally, the investigators are doing this study to identify risk factors for memory and thinking problems in CKD patients. The information received through the NDI will be utilized to help track our study population and help provide useful information regarding cause of death of those in our study.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2021-07-14; most recent amendment 2025-10-31.
Trial Details
NCT Number NCT04975464
Lead Sponsor Anne Murray
Collaborators: National Institute on Aging (NIA), Minneapolis Veterans Affairs Medical Center, Mayo Clinic, HealthPartners Institute
Conditions Chronic Kidney Diseases, Dementia, Dementia, Vascular, Stroke, Alzheimer Disease, Cognitive Decline, Cognitive Impairment, Cognitive Dysfunction +4 more
Enrollment 600 participants
Start Date 2011-11-15
Primary Completion 2026-05 (estimated)
Study Completion 2026-05 (estimated)
Updated on ClinicalTrials.gov 2025-11-04